Valuation: Alpa Laboratories Limited

Market Cap 1.19B 12.69M 11.48M 10.59M 9.59M 18.1M 18.64M 127M 50.54M 638M 47.64M 46.62M 2.03B P/E 2025
11.2x
P/E 2026 6.51x
Enterprise Value -161M -1.71M -1.54M -1.43M -1.29M -2.43M -2.51M -17.11M -6.8M -85.82M -6.41M -6.27M -273M EV / Sales 2025
0.94x
EV / Sales 2026 -0.36x
Free-Float
42.71%
Yield 2025 *
-
Yield 2026 -
10-12 Alpa Laboratories Limited Approves Appointment of Radhika Biyani as an Independent Director, Effective September 30, 2026 CI
09-17 Alpa Laboratories Limited Announces Appointment of Diksha Jaswani as Company Secretary Cum Compliance Officer, Effective September 17, 2026 CI
08-13 Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-23 Alpa Laboratories Ltd. Announces Cessation of Ms. Jyoti Jain as an Independent Director, Effective July 21, 2026 CI
07-08 Alpa Laboratories Limited Announces Resignation of Yashoda Patidar as Company Secretary and Compliance Officer, Effective July 26, 2026 CI
05-29 Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
04-11 Alpa Laboratories Limited Appoints Ms. Yashoda Patidar as Company Secretary and Compliance Officer, Effective April 11, 2026 CI
02-25 Alpa Laboratories Limited Announces Resignation of Srashti Chopra as Company Secretary and Compliance Officer, Effective March 25, 2026 CI
02-12 Alpa Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
13/08/25 Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
01/08/25 Brookfield India Real Estate Trust announced that it expects to receive INR 10.00000015 billion in funding from a group of investors CI
28/05/25 Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
14/02/25 Alpa Laboratories Limited Announces Change in Designation of Vitthal Kothana from Non- Executive Director to Executive Director CI
1 day-1.22%
1 week+4.82%
Current month+12.56%
1 month-0.49%
3 months-16.43%
6 months-20.27%
Current year-27.00%
1 week 51.71
Extreme 51.71
58.95
1 month 46.85
Extreme 46.85
59
Current year 46.1
Extreme 46.1
80.08
1 year 46.1
Extreme 46.1
92.5
3 years 46.1
Extreme 46.1
144.5
5 years 46.1
Extreme 46.1
144.5
10 years 11
Extreme 11
144.5
Manager TitleAgeSince
Chief Executive Officer - 28/05/2016
Director of Finance/CFO 65 -
Director TitleAgeSince
Chairman 83 -
Director/Board Member 77 01/01/1967
Director/Board Member - 28/05/2016
Change 5-day change 1-year change 3-year change Capi.($)
-1.22%+4.82%-32.95%-35.00% 12.88M
-0.70%+4.58%+40.23%+132.95% 1,280B
+1.11%+4.11%+45.85%+92.05% 675B
-0.18%+2.15%+26.25%+112.38% 521B
+1.14%+2.68%+40.80%+71.70% 386B
-0.16%+0.01%+60.69%+43.41% 363B
+1.11%-0.03%+28.96%+60.05% 301B
+0.24%-0.67%+3.45%+38.06% 286B
-0.22%+1.47%+38.89%+75.13% 253B
-1.05%+0.23%+36.10%+124.14% 211B
Average +0.19%+0.15%+28.83%+71.49% 428B
Weighted average by Cap. +0.34%+0.20%+37.66%+95.52%

Financials

2025 2026
Net sales 1.12B 11.96M 10.82M 9.98M 9.04M 17.05M 17.57M 120M 47.63M 601M 44.89M 43.94M 1.91B 1.06B 11.26M 10.18M 9.4M 8.5M 16.05M 16.53M 113M 44.81M 566M 42.24M 41.34M 1.8B
Net income 195M 2.07M 1.88M 1.73M 1.57M 2.96M 3.05M 20.79M 8.26M 104M 7.79M 7.62M 332M 150M 1.6M 1.44M 1.33M 1.21M 2.28M 2.34M 16M 6.36M 80.24M 5.99M 5.86M 255M
Net Debt -1.13B -11.99M -10.84M -10.01M -9.06M -17.09M -17.6M -120M -47.73M -602M -44.99M -44.03M -1.92B -1.35B -14.4M -13.02M -12.02M -10.88M -20.53M -21.15M -144M -57.34M -724M -54.05M -52.89M -2.3B
Projected Income Statement - Annual - Alpa Laboratories Limited
Logo Alpa Laboratories Limited
Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.
Employees
457
Date Price Change Volume
12/11/26 ₹56.71 -1.22% 5,774
11/11/26 ₹57.41 +1.47% 7,290
09/11/26 ₹56.58 +1.16% 27,113
08/11/26 ₹55.93 +4.08% 11,206
06/11/26 ₹53.74 -1.32% 7,971
  1. Stock Market
  2. Stocks
  3. ALPA Stock